Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) shares are up during Friday’s premarket session following the FDA’s accelerated approval of Kresladi (marnetegragene autotemcel),…
Stay informed with the latest market
alerts by subscribing today!
Subscribe and receive daily afternoon commentary and trade opportunities focused on Options Armor.
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the Options Armor newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.
